These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Modulation of immunologic responses in nontuberculous mycobacterial infections with indomethacin. Mason UG; Kirkpatrick CH J Clin Immunol; 1984 Mar; 4(2):112-7. PubMed ID: 6725531 [TBL] [Abstract][Full Text] [Related]
4. Antigen-specific T-cell anergy in progressive Mycobacterium marinum infection in humans. Dattwyler RJ; Thomas J; Hurst LC Ann Intern Med; 1987 Nov; 107(5):675-7. PubMed ID: 3499107 [TBL] [Abstract][Full Text] [Related]
5. Effect of inhibitors of eicosanoid synthesis upon lymphocyte proliferation. Calder PC; Bond JA; Newsholme EA Biochem Soc Trans; 1991 Apr; 19(2):88S. PubMed ID: 1889681 [No Abstract] [Full Text] [Related]
6. The role of the lipoxygenase pathway in T lymphocyte clone function. Jordan ML; Hoffman RA; Simmons RL Transplant Proc; 1987 Feb; 19(1 Pt 1):333-4. PubMed ID: 2856296 [No Abstract] [Full Text] [Related]
7. In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific. Jordan ML; Hoffman RA; Debe EF; Simmons RL J Immunol; 1986 Jul; 137(2):661-8. PubMed ID: 3013998 [TBL] [Abstract][Full Text] [Related]
8. PPD testing as a diagnostic aid in non-tuberculous mycobacteriosis. Clinical and immunological investigations in 4 children with cervical lymphadenitis. Hallberg A; Hallberg T; Holmberg L Acta Paediatr Scand; 1980 Jul; 69(4):511-6. PubMed ID: 6969522 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium fortuitum infection: evidence of bactericidal defect due to hyperactive antigen-specific suppressor cells. Correction in vitro and in vivo by cholinergic agonist and indomethacin. Gardner JD; Ousley M; Godfrey W; Lindsey NJ; Abdou NI Am J Med; 1982 Nov; 73(5):756-64. PubMed ID: 6182796 [TBL] [Abstract][Full Text] [Related]
10. Modulation of lymphocyte responsiveness to phytohemagglutinin by micromolecular fibrinogen degradation products. Janus TJ; Braun DP; Harris JE Clin Immunol Immunopathol; 1986 Oct; 41(1):26-34. PubMed ID: 2943545 [TBL] [Abstract][Full Text] [Related]
11. Immunogenic behaviour of Mycobacterium marinum (SATO) in mice. Srivastava K; Singh NB Indian J Med Res; 1986 Nov; 84():485-91. PubMed ID: 3557568 [No Abstract] [Full Text] [Related]
15. A novel defect in interferon-gamma secretion in patients with refractory nontuberculous pulmonary mycobacteriosis. Safdar A; Armstrong D; Murray HW Ann Intern Med; 2003 Mar; 138(6):521. PubMed ID: 12639099 [No Abstract] [Full Text] [Related]
16. The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. Farrar WL; Humes JL J Immunol; 1985 Aug; 135(2):1153-9. PubMed ID: 3924998 [TBL] [Abstract][Full Text] [Related]
17. Chemical identification of a prostaglandin-induced T suppressor (PITS). Webb DR; Wieder KJ; Rogers TJ; Healy CT; Nowowiejski-Wieder I Lymphokine Res; 1985; 4(2):139-49. PubMed ID: 2987625 [TBL] [Abstract][Full Text] [Related]
18. Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice. Flory CM; Hubbard RD; Collins FM J Leukoc Biol; 1992 Mar; 51(3):225-9. PubMed ID: 1347311 [TBL] [Abstract][Full Text] [Related]
19. Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: a comparison between SENCAR and NMRI mice. Fischer SM; Fürstenberger G; Marks F; Slaga TJ Cancer Res; 1987 Jun; 47(12):3174-9. PubMed ID: 3107806 [TBL] [Abstract][Full Text] [Related]
20. Relationship of thrombin-stimulated arachidonic acid release and metabolism to mitogenesis and phosphatidylinositol synthesis. Raben DM; Yasuda KM; Cunningham DD J Cell Physiol; 1987 Mar; 130(3):466-73. PubMed ID: 3104353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]